Skip to search formSkip to main contentSkip to account menu

LY 277359

Known as: LY-277359, LY277359 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

zatosetron

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety.
The aim of this study was to make a preliminary investigation of the efficacy and safety of zatosetron maleate, a selective 5… 
1994
1994
Chronic toxicity, metabolism, and pharmacokinetics of the 5-HT3 receptor antagonist zatosetron (LY277359) in Fischer 344 rats.
Studies were done to characterize the chronic toxicity, metabolism, and pharmacokinetics of a 5-HT3 receptor antagonist in… 
1991
1991
The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons.
1991
1991
General pharmacology of a new potent 5-hydroxytryptamine antagonist.
The potential of the investigational 5-hydroxytryptamine (5HT3) antagonist, LY277359, to alter cardiovascular, central nervous… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)